يعرض 1 - 10 نتائج من 39 نتيجة بحث عن '"Posthuma, EFM"', وقت الاستعلام: 1.40s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Blommestein , H , de Groot , S , Aarts , MJ , Vemer , P , de Vries , R , Abeelen , AFM , Posthuma , EFM & Uyl - de Groot , C 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005Test

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية

    المصدر: Schuurman , MS , Zandwijk - Hollestein , L , Bastiaannet , E , Posthuma , EFM , van Akkooi , AJC , Kukutsch , NA , Aarts , MJB , Wakkee , M , Lemmens , V & Louwman , MWJ 2019 , ' Melanoma in older patients: declining gap in survival between younger and older patients with melanoma ' , Acta Oncologica , vol. 59 , no. 1 , pp. 4-12 . https://doi.org/10.1080/0284186x.2019.1643914Test

  3. 3
    دورية أكاديمية

    المصدر: Nijdam , A , Dekker , N , Aleman , BMP , Veer , MB , Daniels , LA , van der Maazen , RW , Janus , C , de Weijer , RJ , Zijlstra , JM , Stedema , FG , Ta , BD , Posthuma , EFM , Manenschijn , A , Dielwart , MFH , Bilgin , YM , van den Heuvel , MJ , Boersma , R S , van Leeuwen , FE & Raemaekers , JMM 2019 , ' Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma ' ....

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: Dinmohamed , A , Posthuma , EFM , Visser , O , Kater , AP , Raymakers , RAP & Doorduijn , J 2018 , ' Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands ' , Blood , vol. 131 , no. 12 , pp. 1380-1383 . https://doi.org/10.1182/blood-2017-12-820381Test

  6. 6
    دورية أكاديمية

    المصدر: Dinmohamed , AG , Visser , O , Posthuma , EFM , Huijgens , PC , Sonneveld , P , van de Loosdrecht , AA & Jongen - Lavrencic , M 2017 , ' MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands ' , Cancer Epidemiology , vol. 50 , pp. 137-140 . https://doi.org/10.1016/j.canep.2017.08.016Test

  7. 7
    دورية أكاديمية

    المصدر: Dinmohamed , A , Huijgens , PC , Brink , M , Posthuma , EFM , Uyl - de Groot , C , Blijlevens , NMA , Cornelissen , J & Visser , O 2017 , ' Het hemato-oncologieregister van de Nederlanse Kankerregistratie: verleden, heden en toekomst ' , Nederlands Tijdschrift voor Hematologie , vol. 14 , no. 2 , pp. 55-63 . < http://hdl.handle.net/1765/98465Test >

  8. 8
    دورية أكاديمية

    المصدر: Kersting , S , Levin , MD , Chamuleau , M , Daenen , SMGJ , Dompeling , E C , Doorduijn , J , van Gelder , M , Hoogendoorn , M , Kerst , JM , Nijland , M , Nijziel , MR , Posthuma , EFM , Raymakers , RAP , Schaafsma , MR , Silbermann , MH , Oudemans-van Straaten , HM , Veelken , JH , Vos , J M I , Wittebol , S , van Oers , MHJ & Kater , AP 2016 , ' Dutch guidelines for the diagnosis and treatment ....

  9. 9
    دورية أكاديمية

    المصدر: Dinmohamed , A , van Norden , Y , Visser , O , Posthuma , EFM , Huijgens , PC , Sonneveld , P , van de Loosdrecht , AA & Jongen - Lavrencic , M 2015 , ' Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry ' , Leukemia , vol. 29 , no. 12 , pp. 2449-2451 . https://doi.org/10.1038/leu.2015.220Test

  10. 10
    دورية أكاديمية

    المصدر: van den Broek , EC , Oerlemans , S , Nijziel , MR , Posthuma , EFM , Coebergh , J W & van de Poll-Franse , LV 2015 , ' Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands ' , Annals of Hematology , vol. 94 , no. 1 , pp. 45-56 . https://doi.org/10.1007/s00277-014-2161-6Test